Hörnsten P, Granström M, Wahren B, Gahrton G
Acta Med Scand. 1977;201(5):405-10. doi: 10.1111/j.0954-6820.1977.tb15722.x.
Colony-forming cells (CFC) and colony-stimulating activity (CSA) in peripheral blood cells have been studied before and repeatedly during treatment of 30 patients with acute non-lymphoblastic leukemia. WBC obtained after Isopaque-dextran separation were cultured in vitro by a double-layer agar technique. Before treatment 16 patients out of 30 had CSA and 22 out of 29 had CFC; both CSA and CFC were found in 15 patients. In follow-up studies during treatment, CSA was mainly unaffected during the leukopenic phase, while CFC were suppressed. No CFC were found at WBC counts below 900/mm3. This seems to imply that CFC are more sensitive to cytotoxic agents than colony-stimulating cells. Twelve patients entered remission; all of them had CSA and all the 11 who were investigated for CFC had CFC before treatment. Fourteen out of 18 non-responders lacked one or both types of cells. The presence of CSA and CFC in peripheral blood therefore appears to be a sign of favorable prognosis, while the absence of CSA and/or CFC implies lack of response to treatment.
在对30例急性非淋巴细胞白血病患者的治疗过程中,我们曾对其外周血细胞中的集落形成细胞(CFC)和集落刺激活性(CSA)进行过研究,并在治疗期间多次重复研究。用泛影葡胺-葡聚糖分离法获取的白细胞,采用双层琼脂技术进行体外培养。治疗前,30例患者中有16例存在CSA,29例中有22例存在CFC;15例患者同时存在CSA和CFC。在治疗期间的随访研究中,CSA在白细胞减少期基本未受影响,而CFC受到抑制。白细胞计数低于900/mm3时未发现CFC。这似乎意味着CFC比集落刺激细胞对细胞毒性药物更敏感。12例患者进入缓解期;他们在治疗前均存在CSA,接受CFC检测的11例患者在治疗前均存在CFC。18例未缓解患者中有14例缺乏一种或两种类型的细胞。因此,外周血中存在CSA和CFC似乎是预后良好的标志,而不存在CSA和/或CFC则意味着对治疗无反应。